术后放疗靶区对单侧头颈原发不明癌的影响:倾向性评分多中心研究
该多中心回顾性研究纳入138例单侧头颈原发不明癌术后患者,比较同侧淋巴结区放疗(UL-RT,62例)与双侧淋巴结区联合全咽黏膜放疗(COMP-RT,77例)的疗效。中位随访5年,两组局部区域控制率、对侧淋巴结复发率、肿瘤浮现率及总生存均无显著差异,提示UL-RT可能提供与COMP-RT相似的术后结局。
要点
- 单侧HNCUP术后UL-RT与COMP-RT的5年局部区域控制率分别为80.3%和75.3%(p=0.688)。
- 对侧淋巴结复发率UL-RT为0%、COMP-RT为2.6%(p=0.503),肿瘤浮现率分别为11.5%和9.1%(p=0.778)。
- 总生存(p=0.9516)、特异性生存(p=0.4837)及肿瘤浮现(p=0.9034)均无显著差异。
核心结论
- 在单侧头颈原发不明癌术后管理中,同侧淋巴结区放疗(UL-RT)似乎提供与双侧淋巴结区联合全咽黏膜放疗(COMP-RT)相似的结局。
研究设计与样本
- 多中心回顾性研究纳入2002至2017年间138例单侧HNCUP患者,均经系统全内镜和PET确认无原发灶并初始接受颈淋巴结清扫。
- 放疗分别针对同侧淋巴结区(UL-RT组62例,44%)或双侧淋巴结区及全咽黏膜(COMP-RT组77例,56%),采用倾向性评分匹配平衡基线特征后评估局部区域控制和总生存。
主要发现
- 中位随访5年,UL-RT组与COMP-RT组的局部区域控制率分别为80.3%和75.3%(p=0.688)。
- 对侧淋巴结复发率分别为0%和2.6%(p=0.503),肿瘤浮现率分别为11.5%和9.1%(p=0.778)。
- 总生存(p=0.9516)、特异性生存(p=0.4837)和肿瘤浮现(p=0.9034)在两组间均无显著差异。
- 人群特征包括男性80.4%、吸烟者80.4%、P16阳性肿瘤32.6%、包膜外侵犯71.0%。
临床怎么用
- 对于经全面检查确认无原发灶的单侧HNCUP术后患者,可考虑采用同侧淋巴结区放疗以缩小照射范围。
- 需结合患者个体情况评估对侧淋巴结复发风险,目前数据显示UL-RT组对侧复发率为0%。
局限性
- 本研究为回顾性多中心设计,样本量138例,可能存在选择偏倚。
- 中位随访5年,长期结局需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the impact of two radiation modalities on loco-regional control, survival and tumour emergence, after node dissection for an unilateral head and neck carcinoma of unknown primary (HNCUP). MATERIALS AND METHODS: This is a multicentric retrospective study of 138 patients with unilateral HNCUP treated between 2002 and 2017. The absence of primary tumour was assessed by a systematic panendoscopy and positron emission tomography. Neck dissection was initially performed for all patients. Radiation Therapy was delivered on ipsilateral lymph node areas in 62 cases (44%: UL-RT group) and on bilateral lymph node areas and the entire pharyngeal mucosa in 77 cases (56%: COMP-RT group). Impact of radiation modalities on locoregional control and overall survival was assessed using propensity score matching method in order to balance baseline characteristics between the two groups. RESULTS: The population included 80.4% men, 80.4% smokers, 32.6% P16 positive tumours and 71.0% extracapsular extension. After a median follow-up of 5 years, the locoregional control rate was 80.3% in the UL-RT group and 75.3% in the COMP-RT group (p = 0.688). The corresponding rate of contralateral lymph node recurrence was 0% versus 2.6% (p = 0.503) and the rate of tumour emergence was 11.5% versus 9.1% (p = 0.778). No significant difference was observed between the UL-RT and the COMP-RT groups for overall survival (p = 0.9516), specific survival (p = 0.4837) or tumour emergence (p = 0.9034). CONCLUSION: UL-RT seems to provide similar outcomes as COMP-RT in unilateral HNCUP post-operative management.
引用
- Brenet E, Philouze P, Schiffler C, et al. Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score. Radiother Oncol. 2021. PMID: 33845043. doi:10.1016/j.radonc.2021.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。